Denovo Biopharma LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Denovo Biopharma LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11175
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Denovo Biopharma LLC (Denovo Biopharma), formerly Denovo Biomarkers Inc is a biotechnology company that provides novel biomarker solutions to personalize drug development. The company enables drug developers to design new clinical trials in targeted patient population and re-evaluates medicines failed in general patient populations. Its core technology performs genomic biomarker discovery using archived clinical samples. Denovo Biopharma supports its partners throughout the evolution process up to approval and launch of the drug together with the companion diagnostic test. The company also partners with life science companies and drug developers. It has its operations in the US and China. Denovo Biopharma is headquartered in Wilmington, Delaware, the US.

Denovo Biopharma LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Denovo Biopharma LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Denovo Biopharma LLC, Medical Devices Deals, 2012 to YTD 2018 9
Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Denovo Biopharma Acquires Global Rights to Enzastaurin from Eli Lilly 11
Venture Financing 12
Denovo Biopharma Raises Funds in Series A Financing Round 12
Partnerships 13
ALS Emergency Treatment Fund And Denovo Biomarkers Partner To Explore Personalized Medicine Approach For ALS Treatments 13
Licensing Agreements 14
Denovo Biopharma Enters into Licensing Agreement with Stanford University 14
Denovo Biopharma Enters into Licensing Agreement with Albany Molecular Research 15
Denovo Biopharma Enters into Licensing Agreement with Eli Lilly for Pomaglumetad Methionil 16
Denovo Biopharma LLC – Key Competitors 17
Denovo Biopharma LLC – Key Employees 18
Denovo Biopharma LLC – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Clinical Trials 20
Apr 03, 2018: First Patient Dosed In Pivotal Biomarker-Guided Phase 3 Study Of First Line Therapy With DB102 (enzastaurin) + R-CHOP In Patients With High-Risk Diffuse Large B-Cell Lymphoma 20
Oct 24, 2017: Denovo Biopharma Receives FDAs Permission to Proceed a Phase 3 Clinical Trial with DB102 (Enzastaurin) in the First Line Treatment of High Risk DLBCL 21
Feb 16, 2017: Denovo Biopharma plans to launch a Global Phase 3 Trial of DB102 (Enzastaurin) in Diffuse Large B-cell Lymphoma 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Key Facts 2
Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Denovo Biopharma LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Denovo Biopharma LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Denovo Biopharma LLC, Medical Devices Deals, 2012 to YTD 2018 9
Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Denovo Biopharma Acquires Global Rights to Enzastaurin from Eli Lilly 11
Denovo Biopharma Raises Funds in Series A Financing Round 12
ALS Emergency Treatment Fund And Denovo Biomarkers Partner To Explore Personalized Medicine Approach For ALS Treatments 13
Denovo Biopharma Enters into Licensing Agreement with Stanford University 14
Denovo Biopharma Enters into Licensing Agreement with Albany Molecular Research 15
Denovo Biopharma Enters into Licensing Agreement with Eli Lilly for Pomaglumetad Methionil 16
Denovo Biopharma LLC, Key Competitors 17
Denovo Biopharma LLC, Key Employees 18

List of Figures
Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Denovo Biopharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Denovo Biopharma LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Denovo Biopharma LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • JGC Corp (1963):電力:M&Aディール及び事業提携情報
    Summary JGC Corp (JGC) is an engineering contracting company. It offers engineering, procurement and construction services for various engineering contracts and projects in the areas of oil and gas development, petroleum refining, natural gas processing, petrochemicals, clean energy and power genera …
  • DPT Laboratories Ltd:企業の戦略的SWOT分析
    DPT Laboratories Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Perdana Petroleum Bhd (PERDANA):企業の財務・戦略的SWOT分析
    Perdana Petroleum Bhd (PERDANA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • ABB, Ltd.:企業の戦略・SWOT・財務情報
    ABB, Ltd. - Strategy, SWOT and Corporate Finance Report Summary ABB, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Glaukos Corp (GKOS):医療機器:M&Aディール及び事業提携情報
    Summary Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such …
  • Becton Dickinson and Co (BDX)-製薬・医療分野:企業M&A・提携分析
    Summary Becton Dickinson and Co (BD) is a medical technology company that manufactures and sells medical devices, reagents and instrument. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management …
  • Abide Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Abide Therapeutics Inc (Abide) is a clinical development stage company that discovers and develops therapeutic potential of serine hydrolases to transform the lives of patients with serious unmet medical needs. The company’s pipeline include ABX-1431, a first-in-class inhibitor of the serine …
  • Altice Europe Nv:企業の戦略・SWOT・財務分析
    Altice Europe Nv - Strategy, SWOT and Corporate Finance Report Summary Altice Europe Nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Quidel Corp (QDEL):企業の財務・戦略的SWOT分析
    Quidel Corp (QDEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • CareCloud Corp-医療機器分野:企業M&A・提携分析
    Summary CareCloud Corp (CareCloud) is a healthcare technology company that offers information technology solutions. The company offers cloud-based healthcare IT solutions. It offers solutions such as revenue cycle management, electronic health records, patient engagement, practice management, and ot …
  • Acesur:企業の戦略・SWOT・財務情報
    Acesur - Strategy, SWOT and Corporate Finance Report Summary Acesur - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Eurofins Scientific SE (ERF):製薬・医療:M&Aディール及び事業提携情報
    Summary Eurofins Scientific SE (Eurofins) is a life sciences company, which provides a range of analytical testing services to clients in various industries. The company offers food and feed testing, biopharma services, pharma discovery services, genomic pharma services, pharma early development, ph …
  • Pacific Biosciences of California Inc (PACB):製薬・医療:M&Aディール及び事業提携情報
    Summary Pacific Biosciences of California Inc (Pacific Biosciences) designs, develops, and manufactures sequencing instruments for solving complex genetic abnormalities. The company’s product portfolio comprises proprietary Phospholinked nucleotides, sequencing systems, analytical software and consu …
  • Helomics Corp-製薬・医療分野:企業M&A・提携分析
    Summary Helomics Corp(Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company’s products include chemofx, biospecifx, genefx colon and genefx lung. Its chemofx is a drug response marker, which is used to test tumor …
  • Quantum Fuel Systems LLC (QTWWQ):企業の戦略的SWOT分析
    Quantum Fuel Systems LLC (QTWWQ) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Southern Minnesota Municipal Power Agency:企業の戦略的SWOT分析
    Southern Minnesota Municipal Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • GC Pharma (006280):企業の財務・戦略的SWOT分析
    GC Pharma (006280) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Coloplast AS (COLO B):医療機器:M&Aディール及び事業提携情報
    Summary Coloplast A/S (Coloplast) is a medical device company that offers products and services for ostomy care, urology care, continence care, and skin and wound care. Its major products include ostomy bags; urisheaths; urine bags; catheters; anal irrigation systems; vaginal sling products; advance …
  • MegaChips Corporation (6875):企業の財務・戦略的SWOT分析
    MegaChips Corporation (6875) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Rev1 Ventures Inc.:企業のM&A・事業提携・投資動向
    Rev1 Ventures Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rev1 Ventures Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆